CLINICAL TRIALS PROFILE FOR NYX-783
✉ Email this page to a colleague
Clinical Trials for NYX-783
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT04044664 ↗ | Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder | Completed | Massachusetts General Hospital | Phase 2 | To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population. |
NCT04044664 ↗ | Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder | Completed | Premier Research Group plc | Phase 2 | To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population. |
NCT04044664 ↗ | Safety and Efficacy of NYX-783 in Subjects With Post-Traumatic Stress Disorder | Completed | Aptinyx | Phase 2 | To evaluate the safety, tolerability, and response profile of NYX-783 in a Post-Traumatic Stress Disorder population. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for NYX-783
Condition Name
Clinical Trial Locations for NYX-783
Trials by Country
Clinical Trial Progress for NYX-783
Clinical Trial Phase
Clinical Trial Sponsors for NYX-783
Sponsor Name